Dr. Dylan Sherry leads a conversation with MAPPIT participants discussing their experiences, resources, tips and communication recommendations with buprenorphine for patients with cancer related pain. Chwistek M, Sherry D, Kinczewski L, Silveira MJ, Davis M. Should Buprenorphine Be Considered a First-Line Opioid for the Treatment of Moderate to Severe Cancer Pain?. J Pain Symptom Manage. 2023;66(5):e638-e643. doi:10.1016/j.jpainsymman.2023.06.022
October 2023
